Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1290305
                    [Title] => FDA approves Pharmacyclics, J&J drug for new use in treating rare bone marrow leukemia
                    [Summary] => 
The Food and Drug Administration on Wednesday approved a cancer drug from Pharmacyclics and Johnson & Johnson for a new use against a rare blood and bone marrow disease.

                    [DatePublished] => 2014-02-14 00:23:17
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://premium.mofusecdn.com/80f2c8ee7542896ed15e3296a6cd0df2/cache/post-images/d9a6eed5345ed108fbde6630bebb911d.570.0.0.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 1257009
                    [Title] => FDA approves new drug for rare blood cancer
                    [Summary] => 
The Food and Drug Administration on Wednesday approved a new drug from Pharmacyclics and Janssen Biotech Inc. to treat a rare and aggressive form of blood cancer.

                    [DatePublished] => 2013-11-15 03:26:01
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://premium.mofusecdn.com/80f2c8ee7542896ed15e3296a6cd0df2/cache/post-images/d9a6eed5345ed108fbde6630bebb911d.570.0.0.jpg
                )

        )

)

IMBRUVICA

Array
(
    [results] => Array
        (
            [0] => Array
                (
                    [ArticleID] => 1290305
                    [Title] => FDA approves Pharmacyclics, J&J drug for new use in treating rare bone marrow leukemia
                    [Summary] => 
The Food and Drug Administration on Wednesday approved a cancer drug from Pharmacyclics and Johnson & Johnson for a new use against a rare blood and bone marrow disease.

                    [DatePublished] => 2014-02-14 00:23:17
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://premium.mofusecdn.com/80f2c8ee7542896ed15e3296a6cd0df2/cache/post-images/d9a6eed5345ed108fbde6630bebb911d.570.0.0.jpg
                )

            [1] => Array
                (
                    [ArticleID] => 1257009
                    [Title] => FDA approves new drug for rare blood cancer
                    [Summary] => 
The Food and Drug Administration on Wednesday approved a new drug from Pharmacyclics and Janssen Biotech Inc. to treat a rare and aggressive form of blood cancer.

                    [DatePublished] => 2013-11-15 03:26:01
                    [ColumnID] => 0
                    [Focus] => 0
                    [AuthorID] => 
                    [AuthorName] => 
                    [SectionName] => Health And Family
                    [SectionUrl] => health-and-family
                    [URL] => http://premium.mofusecdn.com/80f2c8ee7542896ed15e3296a6cd0df2/cache/post-images/d9a6eed5345ed108fbde6630bebb911d.570.0.0.jpg
                )

        )

)

abtest

FDA approves Pharmacyclics, J&J drug for new use in treating rare bone marrow leukemia

February 14, 2014 - 12:23am

The Food and Drug Administration on Wednesday approved a cancer drug from Pharmacyclics and Johnson & Johnson for a new...

Health And Family

FDA approves new drug for rare blood cancer

November 15, 2013 - 3:26am

The Food and Drug Administration on Wednesday approved a new drug from Pharmacyclics and Janssen Biotech Inc. to treat a rare...

Health And Family